FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Markus M Lerch Ursula Vehling-Kaiser Clemens Giessen-Jung Tobias Heintges Ludwig Fischer von Weikersthal |
| Publication date | August 26, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |